首页> 美国卫生研究院文献>Influenza and Other Respiratory Viruses >Antibody responses against influenza A(H1N1)pdm09 virus after sequential vaccination with pandemic and seasonal influenza vaccines in Finnish healthcare professionals
【2h】

Antibody responses against influenza A(H1N1)pdm09 virus after sequential vaccination with pandemic and seasonal influenza vaccines in Finnish healthcare professionals

机译:芬兰卫生保健专业人员连续接种大流行性流感和季节性流感疫苗后对甲型H1N1pdm09流感病毒的抗体应答

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

>Background  Influenza A(H1N1)pdm09 virus has been circulating in human population for three epidemic seasons. During this time, monovalent pandemic and trivalent seasonal influenza vaccination against this virus have been offered to Finnish healthcare professionals. It is, however, unclear how well vaccine‐induced antibodies recognize different strains of influenza A(H1N1)pdm09 circulating in the population and whether the booster vaccination with seasonal influenza vaccine would broaden the antibody cross‐reactivity. >Objectives  Influenza vaccine‐induced humoral immunity against several isolates of influenza A(H1N1)pdm09 virus was analyzed in healthcare professionals. Age‐dependent responses were also analyzed. >Methods  Influenza viruses were selected to represent viruses that circulated in Finland during two consecutive influenza epidemic seasons 2009–2010 and 2010–2011. Serum samples from vaccinated volunteers, age 20–64 years, were collected before and after vaccination with AS03‐adjuvanted pandemic and non‐adjuvanted trivalent seasonal influenza vaccine that was given 1 year later. >Results  Single dose of pandemic vaccine induced a good albeit variable antibody response. On day 21 after vaccination, depending on the virus strain, 14–75% of vaccinated had reached antibody titers (≥1:40) considered seroprotective. The booster vaccination 1 year later with a seasonal vaccine elevated the seroprotection rate to 57–98%. After primary immunization, younger individuals (20–48 years) had significantly higher antibody titers against all tested viruses than older persons (49–64 years) but this difference disappeared after the seasonal booster vaccination. >Conclusions  Even a few amino acid changes in influenza A HA may compromise the vaccine‐induced antibody recognition. Older adults (49 years and older) may benefit more from repeated influenza vaccinations.
机译:>背景流感A(H1N1)pdm09病毒已经在三个流行季节在人类中传播。在这段时间里,已经向芬兰卫生保健专业人员提供了针对这种病毒的单价大流行和三价季节性流感疫苗。但是,尚不清楚疫苗诱导的抗体如何很好地识别人群中传播的不同的A(H1N1)pdm09流感病毒株,以及季节性流感疫苗的加强疫苗接种是否会扩大抗体的交叉反应性。 >目标在医疗保健专业人员中分析了流感疫苗诱导的针对几种分离的A(H1N1)pdm09流感病毒分离株的体液免疫。还分析了年龄依赖性反应。 >方法选择流感病毒代表在2009-2010年和2010-2011年连续两个流感流行季节在芬兰传播的病毒。在接种AS1辅助大流行和非辅助三价季节性流感疫苗接种前后,收集了20至64岁的年龄在20-64岁的志愿者的血清样本。 >结果尽管大剂量的大剂量疫苗可产生良好的抗体反应。接种后第21天,根据病毒株的不同,接种疫苗的14%至75%达到了具有血清保护性的抗体滴度(≥1:40)。 1年后使用季节性疫苗加强免疫,使血清保护率提高到57-98%。初次免疫后,年轻个体(20-48岁)对所有测试病毒的抗体效价显着高于老年人(49-64岁),但这种差异在季节性加强免疫后消失。 >结论甲型流感病毒HA中即使有几个氨基酸变化也可能会损害疫苗诱导的抗体识别。年龄较大的成年人(49岁及以上)可能会从反复接种流感疫苗中受益更多。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号